Trials / Unknown
UnknownNCT06277453
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy: Multicenter Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 219 (actual)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To explore the effect of adjuvant chemotherapy cycles on the prognosis of this specific patient with lymph node-negative gastric cancer following neoadjuvant chemotherapy.
Detailed description
We analyzed clinicopathological data from patients with lymph node-negative gastric cancer who underwent neoadjuvant chemotherapy at four institutions between 2010 and 2020. The 3-year OS was assessed using landmark analysis. Independent risk factors associated with 3-year OS were identified using a Cox proportional hazards regression model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | surgery | radical gastric cancer surgery (R0) and D2 lymph node dissection |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-08-25
- Completion
- 2024-09-30
- First posted
- 2024-02-26
- Last updated
- 2024-02-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06277453. Inclusion in this directory is not an endorsement.